G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 109 filers reported holding G1 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $275,600 | -51.8% | 102,836 | -2.4% | 0.00% | – |
Q4 2022 | $572,344 | -55.1% | 105,404 | +3.3% | 0.00% | – |
Q3 2022 | $1,274,000 | +213.8% | 102,008 | +24.1% | 0.00% | – |
Q2 2022 | $406,000 | -34.9% | 82,214 | 0.0% | 0.00% | – |
Q1 2022 | $624,000 | -34.3% | 82,214 | -11.7% | 0.00% | – |
Q4 2021 | $950,000 | -95.7% | 93,078 | -92.5% | 0.00% | -100.0% |
Q4 2020 | $22,259,000 | -35.5% | 1,237,342 | -58.6% | 0.00% | -42.9% |
Q3 2020 | $34,498,000 | -59.0% | 2,986,829 | -13.9% | 0.01% | -63.2% |
Q2 2020 | $84,209,000 | +105.4% | 3,471,032 | -6.7% | 0.02% | +72.7% |
Q1 2020 | $40,998,000 | -70.0% | 3,720,369 | -28.0% | 0.01% | -62.1% |
Q4 2019 | $136,596,000 | +15.6% | 5,168,184 | -0.4% | 0.03% | +7.4% |
Q3 2019 | $118,173,000 | -25.6% | 5,187,573 | +0.1% | 0.03% | -22.9% |
Q2 2019 | $158,844,000 | +106.4% | 5,180,852 | +11.7% | 0.04% | +105.9% |
Q1 2019 | $76,966,000 | +6.6% | 4,636,474 | +23.0% | 0.02% | -5.6% |
Q4 2018 | $72,189,000 | -57.0% | 3,769,615 | +17.5% | 0.02% | -48.6% |
Q3 2018 | $167,809,000 | +36.5% | 3,209,187 | +13.5% | 0.04% | +29.6% |
Q2 2018 | $122,910,000 | +25.8% | 2,828,133 | +7.2% | 0.03% | +22.7% |
Q1 2018 | $97,725,000 | +247.8% | 2,637,648 | +86.2% | 0.02% | +266.7% |
Q4 2017 | $28,098,000 | +34.1% | 1,416,243 | +68.2% | 0.01% | +20.0% |
Q3 2017 | $20,960,000 | +44.0% | 842,089 | +0.9% | 0.01% | +66.7% |
Q2 2017 | $14,555,000 | – | 834,563 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |